Eli Lilly

“This is going to be a trillion dollar drug, trillion dollar, but people are already taking it.”

“The interesting thing here is that in a phase three clinical trial in humans, it caused up to one third loss of body weight. So a loss of one third of body weight in about six months time. And it seems like there's some degree of muscle sparing.”

“No, cause that stuff's going to come down in price and now, you know, Lilly and Novo are smart now with their GLP ones. They're working around the PBMs and doing direct-to-patient, direct-to-company, and that was brilliant. That was really smart.”